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PRRT2 Mutations Cause Benign Familial
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with Choreoathetosis Syndrome
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Benign familial infantile epilepsy (BFIE) is a self-limited seizure disorder that occurs in infancy and has autosomal-dominant inheritance.
We have identified heterozygous mutations in PRRT2, which encodes proline-rich transmembrane protein 2, in 14 of 17 families (82%)
affected by BFIE, indicating that PRRT2mutations are the most frequent cause of this disorder. We also report PRRT2mutations in five of
six (83%) families affected by infantile convulsions and choreoathetosis (ICCA) syndrome, a familial syndrome in which infantile
seizures and an adolescent-onset movement disorder, paroxysmal kinesigenic choreoathetosis (PKC), co-occur. These findings show
that mutations in PRRT2 cause both epilepsy and a movement disorder. Furthermore, PRRT2 mutations elicit pleiotropy in terms of
both age of expression (infancy versus later childhood) and anatomical substrate (cortex versus basal ganglia).Benign familial infantile epilepsy (BFIE) (OMIM 605751) is
an autosomal-dominant seizure disorder that occurs in
infancy and in which seizure onset occurs at a mean age
of 6 months; seizure offset usually occurs by 2 years of
age. Genetic-linkage analyses of families affected by BFIE
have suggested that causative mutations occur in genes
residing at three different chromosomal loci. Guipponi
et al. and Li et al. have reported linkage to chromosomal
regions 19q12–13.11 and 1p362, respectively, in BFIE-
affected families. The vast majority of reported families
(approximately 50) affected by BFIE show linkage to the
pericentromeric region from 16p.11.2–16q12.1.3–7 This
region of chromosome 16 contains more than 150 genes,
and despite concerted efforts by many groups, there has
been no success in determining the underlying genetic
mutation that causes BFIE.
In infantile convulsions and choreoathetosis (ICCA)
syndrome (OMIM 602066), individual family members
can be afflicted with infantile seizures, the adolescent
onset movement disorder paroxysmal kinesigenic chor-
eoathetosis (PKC) (OMIM 128200), or both.When patients
are affected by both of these uncommon clinical pheno-
types, presentation might be separated by many years.1Epilepsy Research Program, School of Pharmacy and Medical Sciences, Unive
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somal-dominant PKC also show linkage to the large peri-
centromeric region of chromosome 16.8–10 The shared
linkage region and co-occurrence of these disorders in
families affected by ICCA have previously led to specula-
tion that BFIE, ICCA, and autosomal-dominant PKCmight
be allelic.8,9 Identification of the gene or genes in which
mutations cause these disorders is required for confirma-
tion of this hypothesis.
We studied 23 families affected by either BFIE (n¼ 17) or
ICCA (n ¼ 6). The study was approved by the Human
Research Ethics Committees of Austin Health and the
Women’s and Children’s Health Network. Informed
consent was obtained from all participants. Individuals
underwent detailed phenotyping involving a validated
seizure questionnaire.11 All previous medical records and
EEG and neuroimaging data were obtained where avail-
able. Australian control samples were obtained from anon-
ymous blood donors. Israeli control samples came from
unaffected, unrelated members of families recruited for
studies on the genetic causes of epilepsy.
We performed linkage analyses to identify families in
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in the gene located in the chromosome 16 region. Microsa-
tellite markers that linked to the BFIE loci on chromosomes
1, 16, and 19 were genotyped by standard methods. We
calculated LOD scores for sufficiently sized families by
using FASTLINK.12 Maximum LOD scores of 3.27, 3.0,
and 2.71 for the chromosome 16 locus were obtained for
families 1, 2, and 5, respectively. We found that data on
families 1–9, 11, and 12 were consistent with linkage to
the chromosomal region 16p11.2–q12.1 (Table 1).
Previous strategies of intensive candidate-gene
sequencing and array comparative genome hybridization
have not revealed the chromosome 16 genetic aberration
that causes BFIE13 (S.E.H. and J.C.M., unpublished data).
We designed a sequence-capture array to extract coding
sequences, minimal promoter sequences, and microRNAs
in the 20.3 Mb linkage interval between the microsatellite
markers D16S3093 and D16S411 on chromosome 16.
Sequence capture, massively parallel sequencing (MPS),
and bioinformatic analysis were performed as described
previously.14,15
MPS was performed on one individual each from fami-
lies 1 and 5. Unique sequence variants were detected in
the brain-expressed genes A2LP, ARMC5, and BCKDK
in the individual from family 5 (Table S1, available online).
The variants in ARMC5 and BCKDK segregated with the
phenotype in this family, and these genes were screened
with Sanger sequencing in ten more BFIE-affected patients
from families for which data were consistent with linkage
to chromosome 16. Only one additional unique coding
variant was identified, and it was therefore concluded
that mutations in neither of these genes cause BFIE.
In a separate study, Chen et al. identified mutations in
PRRT2, located at chromosomal region 16p11.2, in eight
Chinese families affected by autosomal-dominant PKC
by using MPS analysis.16 In the study reported here, DNA
from the probands of 23 families affected by either BFIE
or ICCA was sequenced for the coding regions of PRRT2
(NM_145239.2) with direct Sanger sequencing. We have
now identified five different mutations in PRRT2 in 14 of
17 (82%) families affected by BFIE and in five of six
(83%) families affected by ICCA. Mutations were thus
identified in a total of 19 out of 23 (83%) families in which
some members had been clinically diagnosed with BFIE or
ICCA. The four families in which mutations were not
found were small—they comprised two or three affected
individuals—and were clinically indistinguishable from
the 19 PRRT2-mutation-positive families.
The PRRT2 mutations (NM_145239.2) comprise
two frameshifts (c.629_630insC [p.Ala211Serfs*14] and
c.649_650insC [p.Arg217Profs*8]), which are each pre-
dicted to cause protein truncation (Figure 1), two splice-
site mutations (c.879þ1G>T and c.879þ5G>A), and a
missense mutation (c.950G>A [p.Ser317Asn]). The first
of the splice-site mutations alters the consensus G of the
canonical donor splice site. The second splice-site muta-
tion does not alter an invariant nucleotide but signifi-
cantly reduces the splice-site score (splice-site score calcu-The Americlator) from 8.3 to 4.9. Together with this reduced splice-
site score, the segregation of the mutation in a large
BFIE-affected family and its absence in controls strongly
suggest pathogenicity. The missense mutation alters an
amino acid residue in a PRRT2 transmembrane domain
that has been evolutionarily conserved from zebrafish to
humans (the PRRT2 protein is only found in vertebrates).
Pathogenicity of the p.Ser317Asn substitution is also
supported by PolyPhen-2 and SIFT, which predict the
substitution to be probably damaging and not tolerated,
respectively.
We analyzed family members and controls for the
c.629_630insC and c.649_650insC frameshift mutations
with direct sequencing. We screened family members and
controls for the c.879þ1 and c.879þ5 mutations with
high-resolution melting (HRM) analysis by using the
LightScanner (Idaho Technology, Salt Lake City, UT). We
screened the controls for the c.950G>A mutation with
LightScanner, and we screened family members for the
same mutation by using Sanger sequencing. The PRRT2
mutations segregated with either the BFIE or the ICCA
phenotype in each of the 19 mutation-positive families
(Figure 2, Table 1) and were not present in 92 controls, in
dbSNP, or in 1000 Genomes data. The primer sequences
and PCR conditions used for Sanger sequencing and
screening are available upon request.
In the 19 families in which the PRRT2 mutation segre-
gated, there were a total of 77 mutation-positive individ-
uals with BFIE or ICCA. In addition, there were 23 appar-
ently unaffected individuals with a PRRT2 mutation
(Figure 2). However, an accurate clinical history of the
occurrence of infantile seizures could not always be ob-
tained for older family members, making the precise pene-
trance of the mutations difficult to determine. Only one
individual (4-III-1) with infantile seizures lacked the
familial PRRT2 mutation and was therefore considered a
phenocopy. We also observed two nonsynonymous
PRRT2 sequence variants in the controls: c.647C>T
(p.Pro216Leu) (rs76335820) in 6 of 115 (5.2%) Australian
controls and one patient and c.644C>G (p.Pro215Arg) in
1 of 97 (1%) Sephardic-Jewish controls.
Our results demonstrate that PRRT2 mutations cause
BFIE. We have also shown that two distinct disorders,
BFIE and ICCA, are allelic—that is, are caused bymutations
in the same gene. Detection of PRRT2 mutations in 14 of
17 (82%) BFIE-affected and five of six (83%) ICCA-affected
families indicates that mutations in this gene are the most
common cause of these distinctive epilepsy syndromes.
Fifteen of the 19 mutation-positive families (79%) carry
the same mutation, c.649_650insC, which is seen in 12
BFIE-affected and three ICCA-affected families. It is most
likely that this mutation arose independently in at least
some of the families, given their diverse ethnic origins:
Australasian of Western-European heritage (12), Swedish
(1), and Israeli Sephardic-Jewish (2). Furthermore, genotyp-
ing of three microsatellite markers closely linked to PRRT2
in families 5–8, 11, 12, 14, and 16 (Australian), 9 and 10an Journal of Human Genetics 90, 152–160, January 13, 2012 153
Table 1. Clinical and Genetic Details of Families with PRRT2 Mutations
Linkage Results
Family
Number of
Members with
BFIE or ICCA
Mean Age of
Seizure Onset
(Range) [Data on n]a
Age Range of
Seizure Offset
[Data on n] Phenotype Ethnic Origin Mutation Chromosome 1 Chromosome 16 Chromosome 19
1 9 9 m (7.5–11 m) [3] N/A BFIE Israeli, Ashkenazi
Jewish
c.879þ5G>A excluded Yes. LOD
score: 3.27
ND
2 15 6.7 m (3–12 m) [7] 12–25 m [7] ICCA Scottish c.629_630insC
(p.Ala211Serfs*14)
ND Yes. LOD
score: 3.0
ND
3 3 6 m (5–8 m) [3] 6 m–2 yr [3] BFIE Israeli, Sephardic
Jewish
c.879þ1G>T excluded not excluded excluded
4 14 4.4 m (3–6 m) [8] 5 m–2 yr ICCA Australasian of
Western-European
heritage
c.950G>A
(p.Ser317Asn)
excluded not excluded excluded
5 9 5.2 m (3.5–7 m) [9] 5–14 m [9] ICCA Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
excluded Yes. LOD
score: 2.71
ND
6 7 6.4 m (5–11 m) [6] 5–12 m [6] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
excluded not excluded excluded
7 6 8.2 m (5–10 m) [5] 10–23 m [5] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
not excluded not excluded excluded
8 6 9.5 m (8–13 m) [4] 10 m–3yr [4] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
not excluded not excluded excluded
9 7 6.5 m (5–8 m) [6] 6 m–2yr [5] BFIE Israeli, Sephardic
Jewish
c.649_650insC
(p.Arg217Profs*8)
excluded not excluded excluded
10 3 6.8 m (6–8 m) <2.5 yr BFIE Israeli, Sephardic
Jewish
c.649_650insC
(p.Arg217Profs*8)
ND ND ND
11 3 4.3 m (3–6 m) [3] 3 m–2 yr [3] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
not excluded not excluded not excluded
1
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Table 1. Continued
Linkage Results
Family
Number of
Members with
BFIE or ICCA
Mean Age of
Seizure Onset
(Range) [Data on n]a
Age Range of
Seizure Offset
[Data on n] Phenotype Ethnic Origin Mutation Chromosome 1 Chromosome 16 Chromosome 19
12 4 4.5 m (4–5 m) [2] 5 m–<1 yr [2] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
not excluded not excluded not excluded
13 3 4 m (4 m) [3] 6–16 m [3] BFIE Swedish c.649_650insC
(p.Arg217Profs*8)
ND ND ND
14 3 4.3 m (4–5 m) [3] 5–24 m [3] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
ND ND ND
15 2 3.3 m (3–3.5 m) [2] 4 m [2] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
ND ND ND
16 3 10.7 m (5–18 m) [3] 7–33 m [3] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
ND ND ND
17 9 6.3 m (4–8 m) [4] 5–8 m [4] BFIE Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
ND ND ND
18 4 6 m [1] ICCA Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
ND ND ND
19 4 5.5 m (5–6 m) [2] 6 m [2] ICCA Australasian of
Western-European
heritage
c.649_650insC
(p.Arg217Profs*8)
ND ND ND
Abbreviations are as follows: m, months; N/A, not available; and ND, not done. See text for remaining abbreviations.
a Number of cases from which data is derived in each family.
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Figure 1. Locations of the Five Mutations in the PRRT2 Sequence
(A) Sequence traces showing the five mutations identified in the 19 BFIE- and ICCA-affected families are compared to wild-type traces.
(B) Gene structure of the coding exons of PRRT2 shows the locations of the five mutations in BFIE- and ICCA-affected families.
(C) The structure of PRRT2 shows the locations of the five mutations. The transmembrane (TM) domains are indicated in purple. In (B)
and (C), the frameshift mutations are marked in light blue, the splice-site mutations in dark blue, and the missense mutation in pink.
The lines between (B) and (C) indicate which regions of the protein are coded by the three coding exons.(Sephardic Jewish), and 13 (Swedish) did not show any
common haplotypes (Figure S2), indicating that the muta-
tions are the result of independent mutational events.
The PRRT2 c.649_650insC mutation clearly occurs at
a mutation ‘‘hot spot’’ because it was seen in 15 of the 19
mutation-positive familiesdescribedhere andsixof the eight
Chinese families affected by autosomal-dominant PKC.16
The high frequency of this frameshift mutation is probably
due to the sequence context inwhich it occurs. The insertion
of a cytosine (C) base occurs in a homopolymer of nine C
bases adjacent to four guanine (G) bases. ThisDNA sequence
has the potential to form a hairpin-loop structure, possibly
leading to DNA-polymerase slippage and the insertion of
an extra C base during DNA replication.
The mutations in families 1 and 5 were not readily de-
tected by MPS despite coverage of PRRT2 on the capture
array used for enrichment of sequences from the BFIE
region on chromosome 16. The percentage of reads con-
taining the common insertion mutation in family 5 was
below the threshold set for mutation calling (Figure S1B).
In addition, the reads for the homopolymer tract showed
a variable number of C bases. This illustrates that MPS is
not always a robust method for mutation detection, espe-
cially in ‘‘difficult’’ sequences such as homopolymer tracts
or GC-rich regions.156 The American Journal of Human Genetics 90, 152–160, January 1PRRT2 encodes a 340 amino acid, proline-rich trans-
membrane protein of unknown function. According to
mRNA-expression data (Ensembl) in human tissue,
PRRT2 is expressed primarily in the brain and is most
highly expressed in the cerebral cortex and basal ganglia
(GeneNote). This expression pattern is consistent with
the clinical expression of BFIE and PKC. To investigate
expression of the mouse ortholog, we performed in situ
hybridization on postnatal (P2, P21, and P46) mouse brain
tissue as described previously17 by using a 504 bp antisense
Prrt2 probe that was complementary to all known tran-
scripts. We generated the probe template by cloning
(pGEM-TEasy Vector System) a PCR fragment amplified
frommouse embryonic stem-cell cDNAwith the following
primers: 50-AGATGAAGGGGGTGGAAGAC-30 and 50-TCA
GGACCTCTGTGGTAGGG-30.
Prrt2waswidely expressed in the brain andwas readily de-
tected in regions implicated in BFIE and PKC pathology;
such regions included the cerebral cortex and the basal
ganglia, although expression in the latter was generally
less intense (Figure 3 and data not shown). Although the
molecular functionofPRRT2 isnot known,yeast two-hybrid
studies suggest that PRRT2 interacts with synaptosomal-
associated protein 25 kDa (SNAP25) (OMIM 600322).18
SNAP25 is a presynaptic plasma-membrane-bound protein3, 2012
Figure 2. Pedigrees of Families with PRRT2 Mutations
Pedigrees of the 19 families affected by BFIE or ICCA show the segregation of the PRRT2mutation within each family. Individuals with
a PRRT2mutation are indicated bym/þ, and individuals tested for mutations and found to be negative are indicated byþ/þ. Individuals
for whom the presence of a mutation was inferred on the basis of its presence in relatives are indicated by (m/þ). Four additional families
in which no mutation was detected are not shown.
The American Journal of Human Genetics 90, 152–160, January 13, 2012 157
Figure 3. Expression of Prrt2 in the Murine Brain
Prrt2 is expressed in the murine brain after birth.
(A–E) In situ hybridization analysis of Prrt2 expression in P21 sagittal (A and B) and P46 coronal (D and E) mouse brain sections. Robust,
widespread expression was detected in the cerebral cortex (Cx) and caudate putamen (CPu) at P21 (A) and P46 (D). No signal was gener-
ated by the sense control probe (B–E). Nissl staining of flanking sections shows cell bodies (C–F). The scale bar represents 0.5 mm.involved in neurotransmitter release from synaptic vesicles.
Its putative binding partner PRRT2 might play a role in
this process.
The discovery of PRRT2 mutations associated with
BFIE reveals that PRRT2 plays a role in epilepsy. In ICCA,
three different familial mutations (c.629_630insC,
c.649_650insC, and c.950G>A) were detected, high-
lighting that ICCA is not caused by one particular
mutation. It remains unclear why one individual should
experience infantile seizures, PKC, or both of these pheno-
types within a family affected by ICCA—the pleiotropy is
remarkable in terms of both age of onset and anatomical
substrate. Possible explanations include genetic back-
ground or the influence of the wild-type PRRT2 allele,
which might modify the phenotypic expression of the
mutant allele; the mechanisms underlying such variable
expressivity are not yet understood.
Recently, a homozygous frameshift mutation in PRRT2
has been reported in a consanguineous Iranian family
affected by intellectual disability (ID).19 However, no infor-
mation was given regarding the occurrence of seizures in
either the individuals with ID or their heterozygous
parents. Phenotypic heterogeneity is not uncommon for
genes involved in epilepsy20,21 but is more unusual when
one considers both epilepsy and movement disorders,
which engage different neuronal networks.22 The genetic158 The American Journal of Human Genetics 90, 152–160, January 1overlap between epilepsy and movement disorders has
recently been recognized in glucose-transporter-1 defi-
ciency syndrome, in which both epilepsy and paroxysmal
exercise-induced dyskinesia co-occur in families and
individuals.23,24 The identification of PRRT2 significantly
extends our current knowledge of the molecular basis for
infantile epilepsies25 and continues to expand the impor-
tance of the role of non-ion-channel genes in the patho-
genesis of epilepsy. Although the molecular basis of the
BFIE and ICCA phenotypes has not yet been defined for
approximately 20% of the families affected by these disor-
ders, the identification of a BFIE-associated genetic muta-
tion will assist the classification of autosomal-dominant
infantile seizure syndromes.26 Our findings will also aid
the diagnosis, treatment, prognosis, and genetic coun-
seling of patients with BFIE.Supplemental Data
Supplemental Data include two figures and one table and can be
found with this article online at http://www.ajhg.org.Acknowledgments
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